What you read in 2015: deals, drugs and debacles

December 30, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are her own.

This year’s best-read Breakingviews spanned deals, drugs and debacles. A view on the misfortunes of Malaysia’s 1MDB was our most-read piece this year, followed by a dose of Big Pharma M&A. The futures of Britain, Greece and Singapore were all hot topics, as was Costco’s divorce from American Express and the sale of the Financial Times to Japan’s Nikkei.

The most-read views were:

Malaysia remains fragile despite China power deal

Teva exits Mylan mess with $40.5 bln Allergan deal

Britain’s exit from Europe: 28 days later

Costco customers look like winners in Amex scrum

Financial logic in $1.3 bln FT buy is paper thin

The most-read features were:

The Devil’s Dictionary of Post-Crisis Finance

Singapore at 50 ought to loosen up

Asia’s sly austerity makes debt challenge worse

Review: Building HSBC’s sprawling, flawed empire

Alibaba delivery arm is a financial blind spot

Our most-clicked column was by Breakingviews founder Hugo Dixon, on the Greek prime minister: Time for Alexis Tsipras to keep his nerve.

Global Editor Rob Cox’s most popular column examined the uncertain future of two venerable institutions, the International Monetary Fund and the World Bank: Race to bottom of global subprime begins.

A caveat: our data does not include numbers from Eikon, Reuters.com, or other Thomson Reuters platforms, nor does it take into account readership via syndication.

No comments so far

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/